View Larger Image [68Ga]FAPI-46 Phase 2 clinical development updates Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer 2024 Annual SNMMI Meeting – Toronto, Canada June 9, 2024 Download Presentation sofie_c557hm2025-10-15T16:42:10+00:00June 9th, 2024|Presentations| Share This Story, Choose Your Platform! FacebookXLinkedInPinterest Related Posts Current State of FAP Ligands for Diagnostic Use in Oncology Gallery Current State of FAP Ligands for Diagnostic Use in Oncology June 14th, 2024 Current State of FAP Targeting Radioligands Gallery Current State of FAP Targeting Radioligands May 30th, 2024 Advancements in Diagnostics Gallery Advancements in Diagnostics March 23rd, 2024 Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy Gallery Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy July 25th, 2023 SOFIE FAPI diagnostic-clinical development updates Gallery SOFIE FAPI diagnostic-clinical development updates June 25th, 2023
![[68Ga]FAPI-46 Phase 2 clinical development updates](https://sofie.com/wp-content/uploads/2024/06/FAPI_Presentation2.jpg)
